Browse > Article

Practical Issue of Botulinum Toxin use Liquid Type, Storage and Reuse  

Son, Hee Young (Department of Otorhinolaryngology, Dongnam Institute of Radiological & Medical Sciences)
Publication Information
Journal of the Korean Society of Laryngology, Phoniatrics and Logopedics / v.30, no.1, 2019 , pp. 9-11 More about this Journal
Abstract
Botulinum toxin (BTX) has been widely used to treat muscle spasms in many voice disorders. Most commercially available forms of BTX require reconstitution before use, which may increase the risk of contamination and requires careful titration. Recently, a liquid-type BTX type A (BTX-A) has been developed, which should simplify the procedure and enhance its efficacy. In this session, I will discuss about the differences of BTX-A from existing types and the practical issues associated with it.
Keywords
Botulinum toxin; Dysphonia; Spasm;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Erbguth FJ. Historical Notes on Botulism, Clostridium botulinum, Botulinum Toxin, and the Idea of the Therapeutic Use of the Toxin. Mov Disord 2004;19:S2-6.   DOI
2 Huang W, Foster JA, Rogachefsky AS. Pharmacology of botulinum toxin. J Am Acad Dermatol 2000;43:249-59.   DOI
3 Wheeler A, Smith HS. Botulinum toxins: mechanisms of action, antinociception and clinical applications. Toxicology 2013;306:124-46.   DOI
4 Brin MF, James C, Maltman J. Botulinum toxin type A products are not interchangeable: a review of the evidence. Biologics 2014;8:227-4.   DOI
5 Song YC. The mechanism of action of Botulinum toxin and various therapeutic uses. Korea pharmaceutical information center;2016.
6 Andy P. Botulinum Toxin as a Clinical Product: Manufacture and Pharmacology In Clinical Applications of Botulinum Neurotoxin: K. A. Foster, Current Topics in Neurotoxicity 5. Springer Science+Business Media New York;2014.
7 Kim JE, Song EJ, Choi GS, Lew BL, Sim WY, Kang H. The efficacy and safety of liquid-type botulinum toxin type A for the management of moderate to severe glabellar frown lines. Plast Reconstr Surg 2015;135(3):732-41.   DOI
8 Cha W, Jang JY, Wang SG, Kang JH, Jo MG. Liquid-type Botulinum Toxin Type A in Adductor Spasmodic Dysphonia: A Prospective Pilot Study. J Voice 2017;31(3):378.e19-378.e24.   DOI
9 Barrow EM, Rosen CA, Hapner ER, Smith S, Hatcher JL, Simpson B, et al. Safety and efficacy of multiuse botulinum toxin vials for intralaryngeal injection. Laryngoscope 2015;125(5):1149-54.   DOI
10 Liu A, Carruthers A, Cohen JL, Coleman WP 3rd, Dover JS, Hanke CW, et al. Recommendations and current practices for the reconstitution and storage of botulinum toxin type A. J Am Acad Dermatol 2012;67(3):373-8.   DOI